| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.
|
Mol Ther
|
2006
|
2.41
|
|
2
|
Regional cerebral glucose utilization in patients with a range of severities of unipolar depression.
|
Biol Psychiatry
|
2002
|
2.26
|
|
3
|
Differential effects of 5-HTTLPR genotypes on the behavioral and neural responses to tryptophan depletion in patients with major depression and controls.
|
Arch Gen Psychiatry
|
2006
|
2.09
|
|
4
|
Species-specific calls evoke asymmetric activity in the monkey's temporal poles.
|
Nature
|
2004
|
2.04
|
|
5
|
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
|
J Nucl Med
|
2013
|
1.93
|
|
6
|
Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls.
|
Arch Gen Psychiatry
|
2004
|
1.92
|
|
7
|
Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association.
|
Alzheimers Dement
|
2013
|
1.87
|
|
8
|
P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide.
|
J Nucl Med
|
2010
|
1.62
|
|
9
|
Reduced serotonin type 1A receptor binding in panic disorder.
|
J Neurosci
|
2004
|
1.61
|
|
10
|
P-glycoprotein function at the blood-brain barrier imaged using 11C-N-desmethyl-loperamide in monkeys.
|
J Nucl Med
|
2008
|
1.53
|
|
11
|
The 5-HT1A receptor and 5-HT transporter in temporal lobe epilepsy.
|
Neurology
|
2013
|
1.51
|
|
12
|
Increased myocardial perfusion and sympathoadrenal activation during mild core hypothermia in awake humans.
|
Clin Sci (Lond)
|
2003
|
1.44
|
|
13
|
The process of awakening: a PET study of regional brain activity patterns mediating the re-establishment of alertness and consciousness.
|
Brain
|
2002
|
1.34
|
|
14
|
Imaging neuroinflammation in Alzheimer's disease with radiolabeled arachidonic acid and PET.
|
J Nucl Med
|
2008
|
1.32
|
|
15
|
Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [¹⁸F]2-fluoro-deoxy-D-glucose positron emission tomography and computed tomography.
|
Antimicrob Agents Chemother
|
2012
|
1.32
|
|
16
|
Toward an evolutionary perspective on conceptual representation: species-specific calls activate visual and affective processing systems in the macaque.
|
Proc Natl Acad Sci U S A
|
2004
|
1.27
|
|
17
|
Brain incorporation of 11C-arachidonic acid, blood volume, and blood flow in healthy aging: a study with partial-volume correction.
|
J Nucl Med
|
2004
|
1.25
|
|
18
|
White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions.
|
Brain Res Bull
|
2003
|
1.23
|
|
19
|
Neural correlates of rapid antidepressant response to ketamine in treatment-resistant unipolar depression: a preliminary positron emission tomography study.
|
Biol Psychiatry
|
2013
|
1.21
|
|
20
|
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome.
|
Brain
|
2012
|
1.19
|
|
21
|
Brown fat activation mediates cold-induced thermogenesis in adult humans in response to a mild decrease in ambient temperature.
|
J Clin Endocrinol Metab
|
2013
|
1.18
|
|
22
|
Biodistribution, radiation dose estimates, and in vivo Pgp modulation studies of 18F-paclitaxel in nonhuman primates.
|
J Nucl Med
|
2003
|
1.16
|
|
23
|
5-HT 1A receptors are reduced in temporal lobe epilepsy after partial-volume correction.
|
J Nucl Med
|
2005
|
1.15
|
|
24
|
Imaging incorporation of circulating docosahexaenoic acid into the human brain using positron emission tomography.
|
J Lipid Res
|
2008
|
1.14
|
|
25
|
Human brain imaging and radiation dosimetry of 11C-N-desmethyl-loperamide, a PET radiotracer to measure the function of P-glycoprotein.
|
J Nucl Med
|
2009
|
1.14
|
|
26
|
Lateralization and gender differences in the dopaminergic response to unpredictable reward in the human ventral striatum.
|
Eur J Neurosci
|
2011
|
1.13
|
|
27
|
Antiretroviral tissue kinetics: in vivo imaging using positron emission tomography.
|
Antimicrob Agents Chemother
|
2009
|
1.11
|
|
28
|
Brain uptake of the acid metabolites of F-18-labeled WAY 100635 analogs.
|
J Cereb Blood Flow Metab
|
2003
|
1.10
|
|
29
|
Effects of a alpha 2C-adrenoreceptor gene polymorphism on neural responses to facial expressions in depression.
|
Neuropsychopharmacology
|
2006
|
1.08
|
|
30
|
Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography.
|
J Cereb Blood Flow Metab
|
2002
|
1.07
|
|
31
|
Functional connectivity between somatosensory and visual cortex in early blind humans.
|
Eur J Neurosci
|
2004
|
1.07
|
|
32
|
Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy.
|
Epilepsia
|
2007
|
1.07
|
|
33
|
Age, sex and laterality effects on cerebral glucose metabolism in healthy adults.
|
Psychiatry Res
|
2002
|
1.03
|
|
34
|
Left prefrontal-repetitive transcranial magnetic stimulation (rTMS) and regional cerebral glucose metabolism in normal volunteers.
|
Psychiatry Res
|
2002
|
1.00
|
|
35
|
Nicotine-induced dopamine release in primates measured with [11C]raclopride PET.
|
Neuropsychopharmacology
|
2004
|
1.00
|
|
36
|
No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder.
|
Am J Psychiatry
|
2005
|
0.98
|
|
37
|
Regional rates of cerebral protein synthesis measured with L-[1-11C]leucine and PET in conscious, young adult men: normal values, variability, and reproducibility.
|
J Cereb Blood Flow Metab
|
2008
|
0.97
|
|
38
|
Imaging signal transduction via arachidonic acid in the human brain during visual stimulation, by means of positron emission tomography.
|
Neuroimage
|
2006
|
0.97
|
|
39
|
The effect of antiepileptic drugs on 5-HT-receptor binding measured by positron emission tomography.
|
Epilepsia
|
2006
|
0.96
|
|
40
|
Measurement of regional rates of cerebral protein synthesis with L-[1-11C]leucine and PET with correction for recycling of tissue amino acids: II. Validation in rhesus monkeys.
|
J Cereb Blood Flow Metab
|
2005
|
0.96
|
|
41
|
Neural correlates of rapid antidepressant response to ketamine in bipolar disorder.
|
Bipolar Disord
|
2013
|
0.95
|
|
42
|
Higher in vivo muscarinic-2 receptor distribution volumes in aging subjects with an apolipoprotein E-epsilon4 allele.
|
Synapse
|
2003
|
0.94
|
|
43
|
Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: II. Effects of prefrontal cortex rTMS.
|
Biol Psychiatry
|
2003
|
0.94
|
|
44
|
Speech-induced striatal dopamine release is left lateralized and coupled to functional striatal circuits in healthy humans: a combined PET, fMRI and DTI study.
|
Neuroimage
|
2012
|
0.94
|
|
45
|
Pre- and post-synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson disease: PET studies with [11C]NNC 112 and [18F]FDOPA.
|
Psychiatry Res
|
2008
|
0.93
|
|
46
|
Intensity-dependent regional cerebral blood flow during 1-Hz repetitive transcranial magnetic stimulation (rTMS) in healthy volunteers studied with H215O positron emission tomography: I. Effects of primary motor cortex rTMS.
|
Biol Psychiatry
|
2003
|
0.93
|
|
47
|
Propofol anesthesia does not alter regional rates of cerebral protein synthesis measured with L-[1-(11)C]leucine and PET in healthy male subjects.
|
J Cereb Blood Flow Metab
|
2009
|
0.92
|
|
48
|
Enzyme replacement reverses abnormal cerebrovascular responses in Fabry disease.
|
BMC Neurol
|
2002
|
0.91
|
|
49
|
Abnormal striatal dopaminergic neurotransmission during rest and task production in spasmodic dysphonia.
|
J Neurosci
|
2013
|
0.90
|
|
50
|
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education.
|
J Nucl Med
|
2013
|
0.89
|
|
51
|
18F-FCWAY and 18F-FDG PET in MRI-negative temporal lobe epilepsy.
|
Epilepsia
|
2008
|
0.89
|
|
52
|
A potential cholinergic mechanism of procaine's limbic activation.
|
Neuropsychopharmacology
|
2004
|
0.88
|
|
53
|
The functional DRD3 Ser9Gly polymorphism (rs6280) is pleiotropic, affecting reward as well as movement.
|
PLoS One
|
2013
|
0.88
|
|
54
|
Interregional cerebral metabolic associativity during a continuous performance task (Part II) : differential alterations in bipolar and unipolar disorders.
|
Psychiatry Res
|
2008
|
0.87
|
|
55
|
Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
|
Brain
|
2013
|
0.87
|
|
56
|
Using cerebral white matter for estimation of nondisplaceable binding of 5-HT1A receptors in temporal lobe epilepsy.
|
J Nucl Med
|
2009
|
0.86
|
|
57
|
Propofol decreases in vivo binding of 11C-PBR28 to translocator protein (18 kDa) in the human brain.
|
J Nucl Med
|
2012
|
0.86
|
|
58
|
In vivo muscarinic 2 receptor imaging in cognitively normal young and older volunteers.
|
Synapse
|
2003
|
0.86
|
|
59
|
Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging.
|
Alzheimers Dement
|
2013
|
0.85
|
|
60
|
The utility of (11)C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.
|
J Cereb Blood Flow Metab
|
2011
|
0.85
|
|
61
|
Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease.
|
Surgery
|
2011
|
0.84
|
|
62
|
Use of acute hyperphenylalaninemia in rhesus monkeys to examine sensitivity and stability of the L-[1-11C]leucine method for measurement of regional rates of cerebral protein synthesis with PET.
|
J Cereb Blood Flow Metab
|
2008
|
0.83
|
|
63
|
DRD2/ANKK1 Taq1A polymorphism (rs1800497) has opposing effects on D2/3 receptor binding in healthy controls and patients with major depressive disorder.
|
Int J Neuropsychopharmacol
|
2013
|
0.83
|
|
64
|
Serotonin transporter genotype and depressive phenotype determination by discriminant analysis of glucose metabolism under acute tryptophan depletion.
|
Neuroimage
|
2008
|
0.83
|
|
65
|
Cerebral blood flow in temporal lobe epilepsy: a partial volume correction study.
|
Eur J Nucl Med Mol Imaging
|
2007
|
0.82
|
|
66
|
Clinical utility of functional imaging with ¹⁸F-FDOPA in Von Hippel-Lindau syndrome.
|
J Clin Endocrinol Metab
|
2012
|
0.82
|
|
67
|
Reduced post-synaptic serotonin type 1A receptor binding in bipolar depression.
|
Eur Neuropsychopharmacol
|
2013
|
0.81
|
|
68
|
Brain docosahexaenoic acid [DHA] incorporation and blood flow are increased in chronic alcoholics: a positron emission tomography study corrected for cerebral atrophy.
|
PLoS One
|
2013
|
0.81
|
|
69
|
Lymph Node Activation by PET/CT Following Vaccination With Licensed Vaccines for Human Papillomaviruses.
|
Clin Nucl Med
|
2017
|
0.80
|
|
70
|
Molecular imaging of pediatric brain tumors: comparison of tumor metabolism using ¹⁸F-FDG-PET and MRSI.
|
J Neurooncol
|
2012
|
0.80
|
|
71
|
Catecholamine depletion in first-degree relatives of individuals with mood disorders: An [(18)F]fluorodeoxyglucose positron emission tomography study.
|
Neuroimage Clin
|
2013
|
0.79
|
|
72
|
Differential effects of paroxetine on raphe and cortical 5-HT1A binding: a PET study in monkeys.
|
Neuroimage
|
2005
|
0.79
|
|
73
|
Effects of arterial cannulation stress on regional cerebral blood flow in major depressive disorder.
|
Sci Rep
|
2012
|
0.78
|
|
74
|
Mood stabilizer treatment increases serotonin type 1A receptor binding in bipolar depression.
|
J Psychopharmacol
|
2013
|
0.78
|
|
75
|
High-resolution(18)F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for pituitary adenoma detection in Cushing disease.
|
J Neurosurg
|
2014
|
0.76
|
|
76
|
Recent developments in neurochemical imaging in schizophrenia: an update.
|
Curr Med Chem
|
2013
|
0.76
|
|
77
|
Interregional cerebral metabolic associativity during a continuous performance task (Part I): healthy adults.
|
Psychiatry Res
|
2008
|
0.75
|
|
78
|
Molecular imaging update: advances in MI of the brain.
|
J Nucl Med
|
2007
|
0.75
|
|
79
|
Rapidly Growing Chest Wall Mass in a Case of Sporadic Metastatic Paraganglioma: Imaging With 4 Different PET Radiopharmaceuticals.
|
Clin Nucl Med
|
2016
|
0.75
|
|
80
|
Multitracer PET imaging of bone metastases from paraganglioma: peripheral halo of uptake on 18F-FLT PET mismatching with central uptake of 18F-FDOPA, 18F-fluorodopamine, and 18F-FDG.
|
Eur J Nucl Med Mol Imaging
|
2013
|
0.75
|
|
81
|
SNMMI leadership update: The importance of quality, evidence, and value in nuclear medicine.
|
J Nucl Med
|
2014
|
0.75
|
|
82
|
2018: The Beginning of a New Era.
|
J Cereb Blood Flow Metab
|
2017
|
0.75
|
|
83
|
Amyloid Imaging Coverage with Evidence Development and the IDEAS Study.
|
J Nucl Med
|
2015
|
0.75
|
|
84
|
SNMMI offers education, exhibits, and networking in Vancouver.
|
J Nucl Med
|
2013
|
0.75
|